ACHC on Nasdaq
Acadia Healthcare
Logo: acadiahealthcare.com4
American health care company
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services.3 From Wikipedia, CC BY-SA 4.0
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Concentra Group Holdings Parent, Inc., Elite Health Systems Inc. or BioCorRx Inc., or pick any stock.
- TickerACHC on Nasdaq1
- Industryhealth care1
- HeadquartersFranklin1
- Websitewww.acadiahealthcare.com
- Legal formDelaware corporation1
- Incorporated inDE5
- Business address6100 Tower Circle, Suite 1000, Franklin, Tn 370675
- Filer categoryLarge accelerated filer5
See how the biggest companies compare on our leaderboards
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.3
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs99¢$3.3B
- Income tax1¢$26.0M
Out of $3.3B in revenue.7 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending92¢$571.8M
- Share buybacks8¢$50.0M
Out of $131.9M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.7
Financial statements
Every line of the income statement in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $3.3B | $3.2B | $2.9B |
| Salaries, wages and benefits (including equity-based compensation expense of $31,708, $37,113, and $32,289, respectively) | $1.8B | $1.7B | $1.6B |
| Professional fees | $195.5M | $189.7M | $176.0M |
| Supplies | $118.0M | $112.7M | $106.0M |
| Rents and leases | $48.0M | $47.9M | $46.6M |
| Other operating expenses | $553.3M | $440.8M | $388.9M |
| Income from provider relief fund | -$6.4M | ||
| Depreciation and amortization | $189.2M | $149.6M | $132.3M |
| Interest expense, net | $138.9M | $116.4M | $82.1M |
| Debt extinguishment costs | $1.3M | ||
| Legal settlements expense | $151.0M | $394.2M | |
| Loss on impairment | $1.0B | $17.3M | $9.8M |
| Gain on sale of property | -$8.7M | -$9.7M | |
| Transaction, legal and other costs | $163.6M | $46.8M | $62.0M |
| Total expenses | $4.4B | $2.8B | $3.0B |
| (Loss) income before income taxes | -$1.1B | $341.9M | -$25.4M |
| Provision for (benefit from) income taxes | $26.0M | $77.4M | -$9.7M |
| Net (loss) income | -$1.1B | $264.5M | -$15.7M |
| Net income attributable to noncontrolling interests | -$10.8M | -$8.9M | -$6.0M |
| Net (loss) income attributable to Acadia Healthcare Company, Inc. | -$1.1B | $255.6M | -$21.7M |
| Basic | -$12.16 | $2.79 | -$0.24 |
| Diluted | -$12.16 | $2.78 | -$0.24 |
| Basic | 90.7M shares | 91.6M shares | 90.9M shares |
| Diluted | 90.7M shares | 92.1M shares | 90.9M shares |
| Equity-based compensation expense | $31.7M | $37.1M | $32.3M |
Every line of the balance sheet in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $133.2M | $76.3M | |
| Accounts receivable, net | $440.6M | $365.3M | |
| Other current assets | $240.3M | $135.8M | |
| Total current assets | $814.1M | $577.5M | |
| Property and equipment, net | $3.1B | $2.9B | |
| Goodwill | $1.3B | $2.3B | $2.2B |
| Intangible assets, net | $96.7M | $70.0M | |
| Deferred tax assets | $2.5M | $21.0M | |
| Operating lease right-of-use assets | $134.0M | $118.4M | |
| Other assets | $72.5M | $52.0M | |
| Total assets | $5.5B | $6.0B | |
| Current portion of long-term debt | $28.4M | $76.8M | |
| Accounts payable | $150.4M | $232.7M | |
| Accrued salaries and benefits | $188.6M | $155.4M | |
| Current portion of operating lease liabilities | $21.2M | $25.5M | |
| Other accrued liabilities | $136.6M | $87.5M | |
| Total current liabilities | $525.2M | $577.9M | |
| Long-term debt | $2.5B | $1.9B | |
| Deferred tax liabilities | $66.6M | $83.9M | |
| Operating lease liabilities | $122.0M | $101.8M | |
| Other liabilities | $201.6M | $122.3M | |
| Total liabilities | $3.4B | $2.8B | |
| Redeemable noncontrolling interests | $191.6M | $117.1M | $105.7M |
| Common stock, $0.01 par value; 180,000,000 shares authorized;90,452,843 and 91,775,264 issued and outstanding as of December 31, 2025 and 2024, respectively | $905.0K | $918.0K | |
| Additional paid-in capital | $2.7B | $2.7B | |
| (Accumulated deficit) retained earnings | -$765.8M | $387.3M | |
| Total equity | $1.9B | $3.1B | $2.8B |
| Total liabilities and equity | $5.5B | $6.0B | |
| Preferred stock, par value | $0.01 | $0.01 | |
| Preferred stock, authorized | 10.0M shares | 10.0M shares | |
| Preferred stock, issued | 0 shares | 0 shares | |
| Common stock, par value | $0.01 | $0.01 | |
| Common stock, shares authorized | 180.0M shares | 180.0M shares | |
| Common stock, shares issued | 90.5M shares | 91.8M shares | |
| Common stock, shares outstanding | 90.5M shares | 91.8M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net (loss) income | -$1.1B | $264.5M | -$15.7M |
| Depreciation and amortization | $189.2M | $149.6M | $132.3M |
| Amortization of debt issuance costs | $4.9M | $4.1M | $3.3M |
| Equity-based compensation expense | $31.7M | $37.1M | $32.3M |
| Deferred income taxes | $1.1M | $67.7M | -$94.0M |
| Debt extinguishment costs | $1.3M | ||
| Non-cash legal settlements expense | $3.5M | $394.2M | |
| Loss on impairment | $1.0B | $17.3M | $9.8M |
| Gain on sale of property | -$8.7M | -$9.7M | |
| Other | $1.6M | -$4.7M | $3.2M |
| Accounts receivable, net | -$75.0M | -$2.3M | -$39.0M |
| Other current assets | -$47.2M | -$7.5M | $8.9M |
| Other assets | -$11.3M | $521.0K | $989.0K |
| Accounts payable and other accrued liabilities | $14.9M | -$420.9M | $17.4M |
| Accrued salaries and benefits | $26.7M | $12.1M | $16.5M |
| Other liabilities | $83.3M | $12.2M | $10.8M |
| Government relief funds | -$9.0M | ||
| Net cash provided by operating activities | $131.9M | $129.7M | $462.3M |
| Cash paid for acquisitions, net of cash acquired | -$8.2M | -$53.5M | -$349.0K |
| Cash paid for capital expenditures | -$571.8M | -$690.4M | -$424.1M |
| Proceeds from sale of property and equipment | $23.8M | $10.4M | $29.4M |
| Other | -$90.0K | -$3.0M | -$2.2M |
| Net cash used in investing activities | -$556.2M | -$736.5M | -$397.2M |
| Borrowings on long-term debt | $1.2B | $350.0M | |
| Principal payments on revolving credit facility | -$1.0B | -$15.0M | -$35.0M |
| Principal payments on long-term debt | -$12.2M | -$56.3M | -$21.2M |
| Repayment of long-term debt | -$670.9M | ||
| Payment of debt issuance costs | -$18.6M | -$1.5M | |
| Repurchase of shares for payroll tax withholdings, net of proceeds from stock option exercises | -$4.2M | -$1.3M | -$44.3M |
| Repurchase of common stock | -$50.0M | ||
| Contributions from noncontrolling partners in joint ventures | $8.6M | $5.2M | $3.0M |
| Distributions to noncontrolling partners in joint ventures | -$3.9M | -$3.0M | -$5.1M |
| Cash paid for contingent consideration | -$1.5M | ||
| Other | -$90.0K | $37.0K | |
| Net cash provided by (used in) financing activities | $481.3M | $583.0M | -$62.7M |
| Net increase (decrease) in cash and cash equivalents | $56.9M | -$23.8M | $2.4M |
| Cash paid for interest | $124.7M | $113.4M | $80.7M |
| Cash paid for income taxes | $30.1M | $28.1M | $66.4M |
| Assets acquired, excluding cash | $53.6M | $59.2M | $6.8M |
| Liabilities assumed | -$893.0K | -$4.2M | -$128.0K |
| Contingent consideration issued in connection with an acquisition | -$1.5M | ||
| Redeemable noncontrolling interest resulting from an acquisition | -$44.6M | -$6.3M |
Products and brands
Business model
Since the passage of the Affordable Care Act, which requires U.S. insurers to cover mental health care, Acadia has partnered with non-profit U.S. hospital systems such as Henry Ford Hospital in Michigan, Geisinger Health Systems in Pennsylvania, and the Nebraska Methodist Health System. The for-profit partner typically operates facilities under the names of its non-profit partners, such as Mount Carmel Behavioral Health in Columbus, Ohio, which Acadia operates for Mount Carmel Health System.
Acadia markets directly to individuals with mental health issues, encouraging them to "skip the ER" at their local not-for-profit hospital and come directly to an Acadia facility. It develops relationships with first responders to encourage them to bring people experiencing mental health issues directly to an Acadia facility and with emergency room staff to encourage referrals.
Operations
United States
Acadia operates facilities for patients with behavioral problems, PTSD, trauma, eating disorders and substance abuse. In 2022, it had about 22,500 employees and a daily patient census of about 70,000 patients and was said to be the largest pure-play behavioral health company. Also in 2022, it opened a children's hospital in Chicago, a joint venture facility in Knoxville, and two comprehensive treatment centers. As of that year, Acadia had a network of 242 behavioral healthcare facilities with approximately 10,800 beds in 39 states and Puerto Rico.
In 2014, Acadia entered the methadone-clinic business when it bought CRC Health, a large-addiction treatment chain, from the private equity firm Bain Capital. Acadia rapidly expanded this business, and by late 2024, it operated 165 methadone clinic in 33 states, making it the U.S.'s largest methadone-clinic chain.
Read the full text
United Kingdom
In June 2014, Acadia bought Partnerships in Care, a British provider of mental health and social care services and acquired the mental health assets of Care UK in May 2015.
The UK Competition and Markets Authority investigated Acadia's acquisition of Priory Group over concerns on its impact on competition. It sold 22 behavioral health facilities for £320 million to BC Partners in October 2016.
From Wikipedia’s article on Acadia Healthcare, shared under CC BY-SA 4.0.6
Controversies and legal
Legal and ethical issues
In 2019, Acadia paid $17 million to resolve the allegations made by federal prosecutors in West Virginia that the company had overbilled Medicaid for blood and urine tests.
Acadia formerly operated, through its subsidiary Youth and Family Centered Services of New Mexico, a facility known as Desert Hills. In 2019, Acadia shut down the facility after revelations of sexual abuse. Acadia ultimately settled five lawsuits arising from abuse at the facility. The included one suit, filed by the guardians of a New Mexico minor, in which a Rio Arriba County, New Mexico jury ordered Acadia to pay $405 million in compensatory and punitive damages; in October 2023, Acadia reached an agreement to settle this case and two others for $400 million, without admitting liability.
In January 2024, the Utah Department of Health and Human Services ordered Midvale's Highland Ridge Hospital to hire an independent monitor for ten hours a week to oversee safety compliance. After another series of safety violations in February, licensing officials required Highland to increase oversight to 40 hours per week. In April 2024, Acadia announced plans to close the facility the following month.
In June 2024, Acadia and fellow for-profit Universal Health Services were found by the Senate Committee on Finance and the Senate Committee on Health, Education, Labor, and Pensions to have endangered the welfare of children in their facilities as a result of a business model that optimized revenue instead of optimizing care. The committees' report stated the problems "occur inevitably and by design: they are the direct causal result of a business model that has the incentive to treat children as payouts and provide less than adequate safety and behavioral health treatment in order to maximize operating and profit margin".
Acadia has been criticized for detaining patients in its facilities against their will, even when holding them was not medically necessary. Patients have been held under mental health laws designed to protect them from being a danger to themselves or others, thus increasing payments to the company. Some were released only after a formal complaint or a lawsuit.
In September 2024, Acadia agreed to pay $19.84 million to settle the U.S. Securities and Exchange Commission (SEC)'s allegations of numerous legal violations, including a false billing for medically unnecessary inpatient services. It also was penalized $1.39 million for preventing whistleblowers from coming forward.
Read the full text
Acadia has actively lobbied against bipartisan proposal in the U.S. Congress to expand access to methadone treatment by allowing opioid use disorder patients to pick up methadone at pharmacies, rather than going to clinics.
In December 2024, The New York Times published an investigative report, based on 60 interviews with current and former employees at Acadia's methadone facilities, that found that Acadia personnel frequently falsified medical records used for billing, and often gave methadone to people who did not have opioid addictions but were dependent on other drugs. The report also found the company's methadone counselors carry large caseloads, sometimes more than twice the limits set by state regulators.
On February 13, 2025, Acadia Healthcare announced the closure of Timberline Knolls, a mental health treatment facility in Lemont, Illinois. The decision comes after multiple allegations of misconduct and legal challenges. In 2018, a licensed counselor at the facility was accused of sexually assaulting several patients, allegedly admitting to going "too far" with a 29-year-old patient during three separate therapy sessions. In 2023, another former patient filed a lawsuit against Timberline Knolls, alleging she was repeatedly raped by an employee while receiving treatment for bipolar disorder, borderline personality disorder, and suicidal thoughts.
From Wikipedia’s article on Acadia Healthcare, shared under CC BY-SA 4.0.6
Recent filings
- Oct 8, 2026SCHEDULE 13G
- Sep 25, 20268-K
- Aug 14, 2026SCHEDULE 13G/A
- Aug 13, 2026SCHEDULE 13G/A
- Aug 6, 2026SCHEDULE 13G/A
- Jul 28, 202610-Q
- Jul 28, 20268-K
- Jul 27, 2026SCHEDULE 13G/A
- Jul 27, 20264
- Jun 26, 20264
- May 18, 20268-K
- May 15, 2026SCHEDULE 13G/A
- May 15, 2026SCHEDULE 13G/A
- May 11, 2026SCHEDULE 13G/A
- May 11, 20263
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- Websitewww.acadiahealthcare.com1
- WikipediaAcadia Healthcare
- WikidataQ28407181
- SEC EDGARCIK 1520697
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataAcadia Healthcare on Wikidata
- 2
- 3WikipediaAcadia Healthcare on Wikipedia
- 4Company websiteAcadia Healthcare logo
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16